Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma.
Saved in:
| Title: | Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma. |
|---|---|
| Authors: | Schleifenbaum JK; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany., Heger JM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany., Jost J; MArS Market Access & Pricing Strategy GmbH, Geffelbachstraße 6, 79576, Weil Am Rhein, Germany., Rosato U; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany., Riou S; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany., Borchmann P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany., Walzer S; MArS Market Access & Pricing Strategy GmbH, Geffelbachstraße 6, 79576, Weil Am Rhein, Germany.; State University Baden-Wuerttemberg, Hangstraße 46-50, 79539, Lörrach, Germany.; University of Applied Sciences Weingarten-Ravensburg, Doggenriedstraße 70, 88250, Weingarten, Germany., Mahlich J; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany. Joerg.Mahlich@gmail.com.; DICE, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany. Joerg.Mahlich@gmail.com. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Jul 07; Vol. 151 (7), pp. 203. Date of Electronic Publication: 2025 Jul 07. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40619472 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schleifenbaum+JK%22">Schleifenbaum JK</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Heger+JM%22">Heger JM</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Jost+J%22">Jost J</searchLink>; MArS Market Access & Pricing Strategy GmbH, Geffelbachstraße 6, 79576, Weil Am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Rosato+U%22">Rosato U</searchLink>; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany.<br /><searchLink fieldCode="AU" term="%22Riou+S%22">Riou S</searchLink>; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany.<br /><searchLink fieldCode="AU" term="%22Borchmann+P%22">Borchmann P</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Walzer+S%22">Walzer S</searchLink>; MArS Market Access & Pricing Strategy GmbH, Geffelbachstraße 6, 79576, Weil Am Rhein, Germany.; State University Baden-Wuerttemberg, Hangstraße 46-50, 79539, Lörrach, Germany.; University of Applied Sciences Weingarten-Ravensburg, Doggenriedstraße 70, 88250, Weingarten, Germany.<br /><searchLink fieldCode="AU" term="%22Mahlich+J%22">Mahlich J</searchLink>; Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany. Joerg.Mahlich@gmail.com.; DICE, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany. Joerg.Mahlich@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227902060%22">Journal of cancer research and clinical oncology</searchLink> [J Cancer Res Clin Oncol] 2025 Jul 07; Vol. 151 (7), pp. 203. <i>Date of Electronic Publication: </i>2025 Jul 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Systematic Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7902060 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1335 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201715216%22">01715216 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer Res Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40619472 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00432-025-06249-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 203 Titles: – TitleFull: Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schleifenbaum JK – PersonEntity: Name: NameFull: Heger JM – PersonEntity: Name: NameFull: Jost J – PersonEntity: Name: NameFull: Rosato U – PersonEntity: Name: NameFull: Riou S – PersonEntity: Name: NameFull: Borchmann P – PersonEntity: Name: NameFull: Walzer S – PersonEntity: Name: NameFull: Mahlich J IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 07 Text: 2025 Jul 07 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-1335 Numbering: – Type: volume Value: 151 – Type: issue Value: 7 Titles: – TitleFull: Journal of cancer research and clinical oncology Type: main |
| ResultId | 1 |